Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 16/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.64 |
| ▸ | HPGD | P15428 | 8/20 | 0.64 |
| ▸ | GAA | P10253 | 8/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 10/20 | 0.58 |
| ▸ | CASP1 | P29466 | 7/20 | 0.58 |
| ▸ | CASP7 | P55210 | 6/20 | 0.58 |
| ▸ | GLA | P06280 | 3/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | BAP1 | Q92560 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3324047 | 0.95 | KDM4E (0.57) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL3328903 | 0.88 | KDM4E (0.64) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL3323326 | 0.87 | KDM4E (0.69) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL3326878 | 0.87 | KDM4E (0.59) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL3324905 | 0.86 | ALDH1A1 (0.71) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL5815747 | 0.85 | NPSR1 (0.67) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL7979577 | 0.85 | KDM4E (0.62) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL5231926 | 0.84 | KDM4E (0.52) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL13333236 | 0.83 | KDM4E (0.71) | KDM4EALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL3326234 | 0.83 | KDM4E (0.79) | KDM4EALDH1A1HPGDGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | APP, MAPT, PSEN1 | KDM4E 4115/4885ALDH1A1 2615/4885HPGD 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.